Pharmacy Podcast Network

Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.  Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care. Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.  PPN is a division of RxPR, LLC. Copyright 2026 

  1. 4D AGO

    Reduce Inflammation with Science-Backed Natural Solutions with Samuel Shepherd - Part 1 | Holistic Pharmacy Podcast

    I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.  In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.  Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.  In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net  Website: ValAsta  FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

    47 min
  2. The Three Biggest Healthcare News of 2025| RxRated Podcast

    6D AGO

    The Three Biggest Healthcare News of 2025| RxRated Podcast

    In this episode of the Rated Rx Podcast, pharmacists break down the biggest healthcare news of 2025 and what it actually means for patients and clinicians 👀💊. You hear real pharmacist perspectives on artificial intelligence in healthcare, new federal plans to regulate AI, and why clinical judgment, patient trust, and human decision making still matter more than algorithms 🤖➡️🧠. The conversation also dives into major vaccine policy changes, including updates to newborn hepatitis B vaccination recommendations and why shifts like this raise real concerns for public health 🧬🩺. The crew explains what these changes mean in practice, how misinformation spreads fast, and why prevention still saves lives. Later, the episode tackles the explosion of GLP 1 weight loss medications like semaglutide and tirzepatide. You hear honest discussion about access, cost, compounding risks, and why obesity needs to be treated as a chronic disease instead of a personal failure ⚖️📈. This episode blends news, clinical insight, and real world experience to unpack where healthcare is heading next. This podcast is intended for entertainment and informational purposes only. Listen and Follow Rated Rx 🎙️ Apple Podcasts https://podcasts.apple.com/us/podcast/the-rated-rx-podcast/id1804181016 Spotify https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Facebook https://www.facebook.com/profile.php?id=61574813907982 Instagram https://www.instagram.com/ratedrxpodcast/ TikTok https://www.tiktok.com/@ratedrxpodcast

    43 min
  3. JAN 9

    Doing Things Differently: YARAL Pharma, Pennsylvania Policy, and the Birth Control Pharmacist | TWIRx

    🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.  ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.  📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers. https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care. https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted  3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management. https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide. https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/  🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year. ⭐ Segment 2 — Clinical & Policy Spotlight Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care. She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based resources, clinical updates, and advocacy support—helping expand access to contraception through pharmacies nationwide. 🔔 Closing That wraps up this week’s episode of This Week in Pharmacy. Thanks for tuning in—and thank you again to YARAL Pharma for sponsoring today’s TWIRx. If you enjoyed today’s episode, please share it with a fellow pharmacist, leave a review, and stay connected as we continue to cover the stories shaping the pharmacy profession. See you next week on TWIRx when we celebrate the "50 Most Influential People in Pharmacy" Awards LIVE!!

    1h 37m
4.7
out of 5
169 Ratings

About

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.  Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care. Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.  PPN is a division of RxPR, LLC. Copyright 2026 

You Might Also Like